Showing results (541-550 of 738) with videos related to

Sort By:
Pageof 74
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2020
Synaptic Loss in Primary Tauopathies Revealed by [11 C]UCB-J Positron Emission TomographyNegin Holland, P Simon Jones, George Savulich, et al.
Neurobiology of Aging|February 25, 2021
Imaging tau burden in dementia with Lewy bodies using [18F]-AV1451 positron emission tomographyElijah Mak, Nicolas Nicastro, Maura Malpetti, et al.
Neurobiology of Aging|March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementiaTimothy Rittman, Robin Borchert, Simon Jones, et al.
Brain Communications|March 20, 2023
Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learningWilliam J Scotton, Cameron Shand, Emily Todd, et al.
Plos Computational Biology|May 9, 2022
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomesFrank H Hezemans, Noham Wolpe, Claire O'Callaghan, et al.
Brain : a Journal of Neurology|March 30, 2021
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's diseaseClaire O'Callaghan, Frank H Hezemans, Rong Ye, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Characterizing the association between complement-mediated TMA and cognitive dysfunction using MRI and neurocognitive assessmentPauline K Kosalka, Fahad Hannan, Jeff Hamilton, et al.
Human Brain Mapping|January 13, 2016
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measuresZheng Ye, Charlotte L Rae, Cristina Nombela, et al.
International Journal of Geriatric Psychiatry|May 27, 2021
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gapsKathy Y Liu, Robert Howard, Sube Banerjee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2025
Polygenic risk discriminates Lewy body dementia from Alzheimer's diseaseAnna McKeever, Peter Swann, Maura Malpetti, et al.
Pageof 74